Pengjie Liu
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer.
Journal: Medical oncology (Northwood, London, England)
Published: April 12, 2023
Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway.
Journal: Acta biochimica et biophysica Sinica
Published: February 07, 2022
circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis.
Journal: Journal of receptor and signal transduction research
Published: April 16, 2021
Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 01, 2019
Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.
Journal: Cancer biology & therapy
Published: September 13, 2018
Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
Journal: Annales d'endocrinologie
Published: June 12, 2018
lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.
Journal: Experimental and therapeutic medicine
Published: June 08, 2018
Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors.
Journal: Oncology letters
Published: November 30, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026